{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:18:03Z","timestamp":1787761083067,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Taipei Municipal Wan-Fang Hospital","doi-asserted-by":"publisher","award":["112-wf-f-1"],"award-info":[{"award-number":["112-wf-f-1"]}],"id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118470","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:32:01Z","timestamp":1755739921000},"page":"118470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models"],"prefix":"10.1016","volume":"191","author":[{"given":"Tsung\u2011Ching","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5092","authenticated-orcid":false,"given":"Iin","family":"Narwanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-2304","authenticated-orcid":false,"given":"Bidyadhar","family":"Sethy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Han","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u2011Hwa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-0029","authenticated-orcid":false,"given":"Yi-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-7231","authenticated-orcid":false,"given":"Ming-Hsien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118470_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling","volume":"80","author":"Hunter","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2025.118470_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/13543771003623232","article-title":"Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review, expert","volume":"20","author":"Lavecchia","year":"2010","journal-title":"Opin. Ther. Pat."},{"issue":"6323","key":"10.1016\/j.biopha.2025.118470_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/351242a0","article-title":"Dephosphorylation and activation of a p34cdc2\/cyclin b complex in vitro by human CDC25 protein","volume":"351","author":"Strausfeld","year":"1991","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.biopha.2025.118470_bib4","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1002\/j.1460-2075.1994.tb06750.x","article-title":"Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin e dependent phosphorylation at the G1\/S transition","volume":"13","author":"Hoffmann","year":"1994","journal-title":"Embo J."},{"issue":"45","key":"10.1016\/j.biopha.2025.118470_bib5","doi-asserted-by":"crossref","first-page":"28607","DOI":"10.1074\/jbc.272.45.28607","article-title":"Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1\/Cdc2 but not cyclin A\/Cdk2","volume":"272","author":"Gabrielli","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"Pt 5","key":"10.1016\/j.biopha.2025.118470_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1242\/jcs.109.5.1081","article-title":"Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells","volume":"109","author":"Gabrielli","year":"1996","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2025.118470_bib7","doi-asserted-by":"crossref","first-page":"1324001","DOI":"10.3389\/fphar.2024.1324001","article-title":"Potential of CDC25 phosphatases in cancer research and treatment: key to precision Medicine","volume":"15","author":"Dakilah","year":"2024","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118470_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200503066","article-title":"Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome","volume":"171","author":"Lindqvist","year":"2005","journal-title":"J. Cell Biol."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118470_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-016-2693-2","article-title":"Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies","volume":"416","author":"Sur","year":"2016","journal-title":"Mol. Cell Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118470_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.chembiol.2004.07.007","article-title":"Cdc25 phosphatases and cancer","volume":"11","author":"Kristjansdottir","year":"2004","journal-title":"Chem. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118470_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.onc.1206121","article-title":"Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer","volume":"22","author":"Ngan","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118470_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.celrep.2018.03.039","article-title":"Identification of CDC25 as a common therapeutic target for Triple-Negative breast cancer","volume":"23","author":"Liu","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118470_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3892\/ijo.2025.5733","article-title":"Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6\u2011methyladenosine\u2011mediated post\u2011transcriptional regulation","volume":"66","author":"Zheng","year":"2025","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118470_bib14","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1080\/21655979.2022.2078940","article-title":"CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2025.118470_bib15","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922346","article-title":"Coexpression analysis of the EZH2 gene using the cancer genome Atlas and oncomine databases identifies coexpressed genes involved in biological networks in breast cancer, glioblastoma, and prostate cancer","volume":"26","author":"Zhu","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2025.118470_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820967474","article-title":"Identification of CDC25C as a potential biomarker in hepatocellular carcinoma using bioinformatics analysis","volume":"19","author":"Xun","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"issue":"51","key":"10.1016\/j.biopha.2025.118470_bib17","doi-asserted-by":"crossref","first-page":"85393","DOI":"10.18632\/oncotarget.13381","article-title":"YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process","volume":"7","author":"Leal","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2025.118470_bib18","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.21873\/anticanres.11219","article-title":"Kinomics screening identifies aberrant phosphorylation of CDC25C in FLT3-ITD-positive AML","volume":"36","author":"Perner","year":"2016","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118470_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12885-022-09853-1","article-title":"Biomarker discovery for practice of precision Medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents","volume":"22","author":"Kawata-Shimamura","year":"2022","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118470_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-07-5983","article-title":"CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability","volume":"68","author":"Ray","year":"2008","journal-title":"Cancer Res."},{"issue":"50","key":"10.1016\/j.biopha.2025.118470_bib21","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1038\/sj.onc.1206976","article-title":"Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines","volume":"22","author":"L\u00f6ffler","year":"2003","journal-title":"Oncogene"},{"issue":"6c","key":"10.1016\/j.biopha.2025.118470_bib22","first-page":"4835","article-title":"Cell cycle-related phosphatases CDC25A and b expression correlates with survival in ovarian cancer patients","volume":"20","author":"Broggini","year":"2000","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118470_bib23","first-page":"1764","article-title":"Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas","volume":"9","author":"Xu","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118470_bib24","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/ncomms5770","article-title":"Recurrent CDC25C mutations drive malignant transformation in FPD\/AML","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118470_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/biomedicines11020362","article-title":"CDC25C protein expression correlates with tumor differentiation and clinical outcomes in lung adenocarcinoma","volume":"11","author":"Stern","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2025.118470_bib26","doi-asserted-by":"crossref","first-page":"S1532","DOI":"10.1245\/s10434-015-4595-z","article-title":"MicroRNA-184 deregulated by the MicroRNA-21 promotes tumor malignancy and poor outcomes in Non-small cell lung cancer via targeting CDC25A and c-Myc","volume":"22","author":"Lin","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2025.118470_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112374","article-title":"Medicinal chemistry insights into novel CDC25 inhibitors","volume":"201","author":"Tao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118470_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111696","article-title":"Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries","volume":"183","author":"Jing","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2025.118470_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrd963","article-title":"Dual-specificity phosphatases as targets for antineoplastic agents","volume":"1","author":"Lyon","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5A","key":"10.1016\/j.biopha.2025.118470_bib30","first-page":"3067","article-title":"Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284)","volume":"27","author":"Guo","year":"2007","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118470_bib31","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3390\/molecules27082389","article-title":"A comprehensive overview of the developments of Cdc25 phosphatase inhibitors","volume":"27","author":"Abdelwahab","year":"2022","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.biopha.2025.118470_bib32","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.7150\/jca.31329","article-title":"CDC25A facilitates Chemo-resistance in ovarian cancer multicellular spheroids by promoting E-cadherin expression and arresting cell cycles","volume":"10","author":"Sun","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118470_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41419-025-07598-w","article-title":"CDC25A inhibition sensitizes melanoma cells to doxorubicin and NK cell therapy","volume":"16","author":"Gao","year":"2025","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.118470_bib34","doi-asserted-by":"crossref","first-page":"18414","DOI":"10.3390\/molecules191118414","article-title":"Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms","volume":"19","author":"Brenner","year":"2014","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2025.118470_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/annonc\/mdh215","article-title":"A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer","volume":"15","author":"Winegarden","year":"2004","journal-title":"Ann. Oncol."},{"issue":"5c","key":"10.1016\/j.biopha.2025.118470_bib36","first-page":"4535","article-title":"Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial","volume":"19","author":"Gridelli","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2025.118470_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12935-020-01304-w","article-title":"The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.biopha.2025.118470_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3892\/ijmm.2016.2475","article-title":"Silencing CDC25A inhibits the proliferation of liver cancer cells by downregulating IL\u20116 in vitro and in vivo","volume":"45","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118470_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12935-022-02448-7","article-title":"PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression","volume":"22","author":"Chen","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2025.118470_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2021.03.022","article-title":"BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53\/CDC25C and P53\/GADD45 pathways in breast cancer","volume":"553","author":"Mo","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118470_bib41","article-title":"SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis","volume":"6","author":"Tang","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.biopha.2025.118470_bib42","article-title":"CDC25C as a predictive biomarker for immune checkpoint inhibitors in patients with lung adenocarcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500664X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500664X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:16:01Z","timestamp":1772810161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500664X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S075333222500664X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118470","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118470"}}